ilShinbiobase Co. Ltd (068330) — Capital Reinvestment Ratio
ilShinbiobase Co. Ltd (068330) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩3.46 Billion) in capital expenditures (₩38.55 Million). See ilShinbiobase Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ilShinbiobase Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks ilShinbiobase Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. See 068330 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for ilShinbiobase Co. Ltd from 2014 to 2025. For the full cash flow conversion analysis, see how efficiently does ilShinbiobase Co. Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | ₩5.27 Billion | ₩20.64 Million | ▼ -69.8% |
| 2024 | 0.01x | ₩4.12 Billion | ₩53.53 Million | ▼ -70.6% |
| 2023 | 0.04x | ₩5.92 Billion | ₩262.17 Million | ▼ -77.6% |
| 2022 | 0.20x | ₩2.65 Billion | ₩522.59 Million | ▲ +857.4% |
| 2021 | 0.02x | ₩6.74 Billion | ₩139.12 Million | ▼ -89.6% |
| 2020 | 0.20x | ₩4.50 Billion | ₩892.64 Million | ▲ +348.1% |
| 2019 | 0.04x | ₩5.55 Billion | ₩245.41 Million | ▼ -44.1% |
| 2018 | 0.08x | ₩4.88 Billion | ₩385.81 Million | ▼ -59.0% |
| 2017 | 0.19x | ₩2.11 Billion | ₩407.59 Million | ▲ +113.2% |
| 2016 | 0.09x | ₩3.01 Billion | ₩271.94 Million | ▼ -75.4% |
| 2015 | 0.37x | ₩270.22 Million | ₩99.39 Million | ▲ +1105.2% |
| 2014 | 0.03x | ₩3.33 Billion | ₩101.50 Million | — |